228 related articles for article (PubMed ID: 9141216)
1. Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo.
del Guercio MF; Alexander J; Kubo RT; Arrhenius T; Maewal A; Appella E; Hoffman SL; Jones T; Valmori D; Sakaguchi K; Grey HM; Sette A
Vaccine; 1997 Mar; 15(4):441-8. PubMed ID: 9141216
[TBL] [Abstract][Full Text] [Related]
2. The optimization of helper T lymphocyte (HTL) function in vaccine development.
Alexander J; Fikes J; Hoffman S; Franke E; Sacci J; Appella E; Chisari FV; Guidotti LG; Chesnut RW; Livingston B; Sette A
Immunol Res; 1998; 18(2):79-92. PubMed ID: 9844827
[TBL] [Abstract][Full Text] [Related]
3. Plasmodium vivax promiscuous T-helper epitopes defined and evaluated as linear peptide chimera immunogens.
Caro-Aguilar I; Rodríguez A; Calvo-Calle JM; Guzmán F; De la Vega P; Patarroyo ME; Galinski MR; Moreno A
Infect Immun; 2002 Jul; 70(7):3479-92. PubMed ID: 12065487
[TBL] [Abstract][Full Text] [Related]
4. Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses.
Alexander J; del Guercio MF; Maewal A; Qiao L; Fikes J; Chesnut RW; Paulson J; Bundle DR; DeFrees S; Sette A
J Immunol; 2000 Feb; 164(3):1625-33. PubMed ID: 10640784
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP1(19) and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus).
Rosa DS; Iwai LK; Tzelepis F; Bargieri DY; Medeiros MA; Soares IS; Sidney J; Sette A; Kalil J; Mello LE; Cunha-Neto E; Rodrigues MM
Microbes Infect; 2006 Jul; 8(8):2130-7. PubMed ID: 16797207
[TBL] [Abstract][Full Text] [Related]
6. Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin.
Yang C; Collins WE; Xiao L; Saekhou AM; Reed RC; Nelson CO; Hunter RL; Jue DL; Fang S; Wohlhueter RM; Udhayakumar V; Lal AA
Vaccine; 1997 Mar; 15(4):377-86. PubMed ID: 9141208
[TBL] [Abstract][Full Text] [Related]
7. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
[TBL] [Abstract][Full Text] [Related]
8. Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice.
Perlaza BL; Sauzet JP; Balde AT; Brahimi K; Tall A; Corradin G; Druilhe P
Eur J Immunol; 2001 Jul; 31(7):2200-9. PubMed ID: 11449374
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of synthetic peptide constructs based on PvMSP9
Rodrigues-da-Silva RN; Correa-Moreira D; Soares IF; de-Luca PM; Totino PRR; Morgado FN; Oliveira Henriques MDG; Peixoto Candea AL; Singh B; Galinski MR; Moreno A; Oliveira-Ferreira J; Lima-Junior JDC
Vaccine; 2019 Jan; 37(2):306-313. PubMed ID: 30509693
[TBL] [Abstract][Full Text] [Related]
10. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types.
Nardin EH; Calvo-Calle JM; Oliveira GA; Nussenzweig RS; Schneider M; Tiercy JM; Loutan L; Hochstrasser D; Rose K
J Immunol; 2001 Jan; 166(1):481-9. PubMed ID: 11123327
[TBL] [Abstract][Full Text] [Related]
11. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
[TBL] [Abstract][Full Text] [Related]
12. Pan DR binding sequence provides T-cell help for induction of protective antibodies against Plasmodium yoelii sporozoites.
Franke ED; Hoffman SL; Sacci JB; Wang R; Charoenvit Y; Appella E; Chesnut R; Alexander J; Del Guercio MF; Sette A
Vaccine; 1999 Mar; 17(9-10):1201-5. PubMed ID: 10195633
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein.
Nardin EH; Calvo-Calle JM; Oliveira GA; Clavijo P; Nussenzweig R; Simon R; Zeng W; Rose K
Vaccine; 1998 Apr; 16(6):590-600. PubMed ID: 9569470
[TBL] [Abstract][Full Text] [Related]
14. Linear and multiple antigen peptides containing defined T and B epitopes of the Plasmodium yoelii circumsporozoite protein: antibody-mediated protection and boosting by sporozoite infection.
Marussig M; Rénia L; Motard A; Miltgen F; Pétour P; Chauhan V; Corradin G; Mazier D
Int Immunol; 1997 Dec; 9(12):1817-24. PubMed ID: 9466309
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC).
Udhayakumar V; Saekhou A; Fang S; Jue D; Wohlhueter RM; Lal AA
Vaccine; 1998; 16(9-10):982-8. PubMed ID: 9682348
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing P. vivax CS epitopes in Aotus monkeys.
Herrera S; De Plata C; González M; Perlaza BL; Bettens F; Corradin G; Arévalo-Herrera M
Parasite Immunol; 1997 Apr; 19(4):161-70. PubMed ID: 9149283
[TBL] [Abstract][Full Text] [Related]
17. Multiple antigen peptide vaccines against Plasmodium falciparum malaria.
Mahajan B; Berzofsky JA; Boykins RA; Majam V; Zheng H; Chattopadhyay R; de la Vega P; Moch JK; Haynes JD; Belyakov IM; Nakhasi HL; Kumar S
Infect Immun; 2010 Nov; 78(11):4613-24. PubMed ID: 20823210
[TBL] [Abstract][Full Text] [Related]
18. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
Koski GK; Ploton IN; Viscidi R; Kumar N
Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein.
Yazdani SS; Shakri AR; Mukherjee P; Baniwal SK; Chitnis CE
Vaccine; 2004 Sep; 22(27-28):3727-37. PubMed ID: 15315853
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.
de Oliveira GA; Clavijo P; Nussenzweig RS; Nardin EH
Vaccine; 1994 Aug; 12(11):1012-7. PubMed ID: 7526570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
